Feng Bingzheng
Overview
Explore the profile of Feng Bingzheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mei L, Yuwei Y, Weiping L, Zhiran X, Bingzheng F, Jibing C, et al.
Cell Transplant
. 2024 Jun;
33:9636897241259433.
PMID: 38877672
Islet transplantation may be the most efficient therapeutic technique for patients with type 1 diabetes mellitus (T1DM). However, the clinical application of this method is faced with numerous limitations, including...
2.
Jibing C, Weiping L, Yuwei Y, Bingzheng F, Zhiran X
Regen Ther
. 2024 Jan;
25:101-112.
PMID: 38178928
Based on engineered cell/exosome technology and various skin-related animal models, exosomal microRNA (miRNA)-based therapies derived from natural exosomes have shown good therapeutic effects on nine skin diseases, including full-thickness skin...
3.
Minhua Q, Bingzheng F, Zhiran X, Yingying Z, Yuwei Y, Ting Z, et al.
Curr Stem Cell Res Ther
. 2023 May;
19(5):669-677.
PMID: 37165494
Exosomal-microRNAs (Exo-miRNAs) are key regulators of islet cell function, including insulin expression, processing, and secretion. Exo-miRNAs have a significant impact on the outcomes of islet transplantation as biomarkers for evaluating...
4.
Zhoujun Z, Bingzheng F, Yuwei Y, Yingying Z, Zhiran X, Chunhua H, et al.
Artif Organs
. 2023 Apr;
47(8):1298-1308.
PMID: 37032529
Background: Islet cell transplantation is an emerging therapy in the treatment of diabetes mellitus. Differentiation of islet cells from mesenchymal stem cells (MSCs) is a potential solution to the challenge...